Allergy Testing Access Act of 2021

United States117th CongressS-701Senate
Updated: Mar 11, 2021

Summary

Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-4114: Allergy Testing Access Act of 2021

Referred to the Subcommittee on Health.

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Finance.

    Senate

All available records shown.